Started protocol with healthy volunteers aged 18-60 years, vaccinated with ADS-M more than 10 years ago, to participate in a clinical trial of a new vaccine against diphtheria, pertussis and tetanus. aAKDS-M is compared with the Adacel vaccine, there is no placebo